Pirkanmaa region launches screening pilot for chronic kidney disease among residents aged 55
Wednesday 4th December 2024 on 06:43 in
Finland
In an effort to enhance early detection of chronic kidney disease, the Pirkanmaa welfare region will launch a screening pilot aimed at residents aged 55. A total of 8,000 individuals born in 1969 and 1970 will receive invitations for this screening initiative. Testing will involve urine and blood samples, with an aim to encourage at least half of those invited to participate.
Chronic kidney disease is a pressing public health issue, affecting one in ten adults, many of whom are unaware of their condition. According to Satu Mäkelä, head physician of nephrology at Tampere University Hospital, early detection is crucial as the disease is asymptomatic in its initial stages but can become life-threatening, potentially necessitating dialysis or a kidney transplant.
Chronic kidney disease refers to the gradual decline in kidney function, leading to permanent changes and inefficient waste removal from the blood. With appropriate lifestyle modifications and, if necessary, medication, the progression of the disease can be slowed or even prevented.
The screening specifically targets at-risk groups, including individuals with diabetes, hypertension, or cardiovascular diseases, as the prevalence of chronic kidney disease notably increases after the age of 50. Residents aged 55 from specific healthcare service areas will be invited, including regions such as Akaa, Lempäälä, and Tampere.
Healthcare staff at the participating centers will undergo additional training regarding the screening process, and invitations will be sent out through personalized letters towards the end of this year and early next year. The screening will use two straightforward laboratory tests, starting with a urine sample to check for any kidney damage, followed by a blood test to assess the kidneys’ filtering capability.
The primary goal of this pilot is to improve early identification of chronic kidney disease while also gathering insights on the effectiveness of systematic population screenings. This initiative aims to foster better health outcomes for patients and reduce costs for the welfare region.